Literature DB >> 24566915

Liver fibrosis and repair: immune regulation of wound healing in a solid organ.

Antonella Pellicoro1, Prakash Ramachandran1, John P Iredale1, Jonathan A Fallowfield1.   

Abstract

Fibrosis is a highly conserved and co-ordinated protective response to tissue injury. The interaction of multiple pathways, molecules and systems determines whether fibrosis is self-limiting and homeostatic, or whether it is uncontrolled and excessive. Immune cells have been identified as key players in this fibrotic cascade, with the capacity to exert either injury-inducing or repair-promoting effects. A multi-organ approach was recently suggested to identify the core and regulatory pathways in fibrosis, with the aim of integrating the wealth of information emerging from basic fibrosis research. In this Review, we focus on recent advances in liver fibrosis research as a paradigm for wound healing in solid organs and the role of the immune system in regulating and balancing this response.

Entities:  

Mesh:

Year:  2014        PMID: 24566915     DOI: 10.1038/nri3623

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  113 in total

Review 1.  Regulation of PDGF and its receptors in fibrotic diseases.

Authors:  James C Bonner
Journal:  Cytokine Growth Factor Rev       Date:  2004-08       Impact factor: 7.638

2.  CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice.

Authors:  Tomonori Aoyama; Sayaka Inokuchi; David A Brenner; Ekihiro Seki
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

3.  Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.

Authors:  Vivian Barry-Hamilton; Rhyannon Spangler; Derek Marshall; Scott McCauley; Hector M Rodriguez; Miho Oyasu; Amanda Mikels; Maria Vaysberg; Haben Ghermazien; Carol Wai; Carlos A Garcia; Arleene C Velayo; Brett Jorgensen; Donna Biermann; Daniel Tsai; Jennifer Green; Shelly Zaffryar-Eilot; Alison Holzer; Scott Ogg; Dung Thai; Gera Neufeld; Peter Van Vlasselaer; Victoria Smith
Journal:  Nat Med       Date:  2010-09-05       Impact factor: 53.440

4.  Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses.

Authors:  Z Shi; A E Wakil; D C Rockey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice.

Authors:  Isao Sakaida; Shuji Terai; Naoki Yamamoto; Koji Aoyama; Tsuyoshi Ishikawa; Hiroshi Nishina; Kiwamu Okita
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

6.  Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats.

Authors:  Christopher J Parsons; Blair U Bradford; Clark Q Pan; Ellen Cheung; Michael Schauer; Andreas Knorr; Barbara Krebs; Sabine Kraft; Stefan Zahn; Bodo Brocks; Nikki Feirt; Baisong Mei; Myung-Sam Cho; Roopa Ramamoorthi; Greg Roldan; Paul Ng; Peggy Lum; Claudia Hirth-Dietrich; Adrian Tomkinson; David A Brenner
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

7.  Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice.

Authors:  Claudia Mitchell; Dominique Couton; Jean-Pierre Couty; Marie Anson; Anne-Marie Crain; Vinciane Bizet; Laurent Rénia; Stanislas Pol; Vincent Mallet; Hélène Gilgenkrantz
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

8.  Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations.

Authors:  Shuei Liong Lin; Ana P Castaño; Brian T Nowlin; Mark L Lupher; Jeremy S Duffield
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

Review 9.  Angiogenesis in liver disease.

Authors:  Mercedes Fernández; David Semela; Jordi Bruix; Isabelle Colle; Massimo Pinzani; Jaume Bosch
Journal:  J Hepatol       Date:  2008-12-31       Impact factor: 25.083

10.  Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution.

Authors:  Prakash Ramachandran; John P Iredale
Journal:  J Hepatol       Date:  2012-02-04       Impact factor: 25.083

View more
  424 in total

1.  TNFα in liver fibrosis.

Authors:  Yoon Mee Yang; Ekihiro Seki
Journal:  Curr Pathobiol Rep       Date:  2015-09-30

Review 2.  Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis.

Authors:  Johan Kreuger; Mia Phillipson
Journal:  Nat Rev Drug Discov       Date:  2015-11-27       Impact factor: 84.694

Review 3.  Update on macrophages and innate immunity in scleroderma.

Authors:  Jennifer J Chia; Theresa T Lu
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

Review 4.  Intestinal fibrosis: ready to be reversed.

Authors:  Giovanni Latella; Florian Rieder
Journal:  Curr Opin Gastroenterol       Date:  2017-07       Impact factor: 3.287

5.  Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic type 2 inflammation.

Authors:  Zhixuan Loh; Rebecca L Fitzsimmons; Robert C Reid; Divya Ramnath; Andrew Clouston; Praveer K Gupta; Katharine M Irvine; Elizabeth E Powell; Kate Schroder; Jennifer L Stow; Matthew J Sweet; David P Fairlie; Abishek Iyer
Journal:  Br J Pharmacol       Date:  2019-08-17       Impact factor: 8.739

6.  Hepatoprotective Effect of Probiotic Lactic Acid Bacteria on Thioacetamide-Induced Liver Fibrosis in Rats.

Authors:  Chittapon Jantararussamee; Siripa Rodniem; Malai Taweechotipatr; Udomsri Showpittapornchai; Wisuit Pradidarcheep
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

7.  Bromodomain and Extraterminal (BET) Proteins Regulate Hepatocyte Proliferation in Hepatocyte-Driven Liver Regeneration.

Authors:  Jacquelyn O Russell; Sungjin Ko; Harvinder S Saggi; Sucha Singh; Minakshi Poddar; Donghun Shin; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2018-03-12       Impact factor: 4.307

8.  Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis.

Authors:  Resat Cinar; Malliga R Iyer; Ziyi Liu; Zongxian Cao; Tony Jourdan; Katalin Erdelyi; Grzegorz Godlewski; Gergő Szanda; Jie Liu; Joshua K Park; Bani Mukhopadhyay; Avi Z Rosenberg; Jeih-San Liow; Robin G Lorenz; Pal Pacher; Robert B Innis; George Kunos
Journal:  JCI Insight       Date:  2016-07-21

9.  Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules.

Authors:  Ximin Shi; Haiqun Xing; Xiaobo Yang; Fang Li; Shaobo Yao; Hui Zhang; Haitao Zhao; Marcus Hacker; Li Huo; Xiang Li
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-29       Impact factor: 9.236

10.  Development of an in vitro model to test antifibrotic drugs on primary human liver myofibroblasts.

Authors:  Lynda Aoudjehane; Pierre-Yves Boelle; Grégoire Bisch; Rolland Delelo; François Paye; Olivier Scatton; Chantal Housset; Jérôme Becquart; Yvon Calmus; Filomena Conti
Journal:  Lab Invest       Date:  2016-03-07       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.